“RBD Dimer recombinant protein vaccine against SARSCoV2” (RBDCOV) is a new Horizon Europe project led by the biotech pharmaceutical company HIPRA. Launched on 1st December, RBDCOV project objective is to test the efficacy, tolerability, and safety of the HIPRA’s recombinant …

Photo by Piron Guillaume on Unplash …

Research led by the Departments of Dermatology, Pathology and Molecular Genetics of the Hospital Universitari Arnau de Vilanova de Lleida (HUAV) and the Oncological Pathology research group of the Universitat de Lleida (UdL) and the Institute for Research in Biomedicine of Lleida (IRBLleida) has identified …

Lleida, through the Clinical Trials unit of the Biomedical Research Institute of Lleida (IRBLleida), is participating in the Destiny-Breast clinical trials programme to tackle HER2+ breast cancer. Specifically, it has participated in Destiny-Breast 2 and is currently participating in Destiny-Breast 5, which involves patients with …

The use of emerging senolytic drugs, which attack senescent or ageing cells, could improve people who have suffered an ischaemic stroke due to a lack of blood flow to the brain. This is according to research by the University of Lleida (UdL) and the Institute …

The therapeutic advances are in contrast to the devastating effects that COVID-19 has had on the evolution of many patients Fifteen patients from the Cognitive Disorders Unit of the University Hospital of Santa Maria (HUSM) have taken part in the clinical trials that have led …

Research by the UdL and IRBLleida describes how they are necessary for the formation and migration of interneurons Defects in the formation and migration of interneurons or inhibitory neurons in the cerebral cortex, related to disorders such as schizophrenia or autism spectrum syndromes, could be …

The Metabolic Pathophysiology group of the UdL-IRBLleida participates in a project to improve the understanding of Alexander disease, a rare disease that progressively destroys the white matter of the brain. The Fundació “la Caixa” has announced today the 30 projects selected in the CaixaResearch call …

Colorectal cancer (CRC) is the most frequent neoplasm in Western countries, the second most frequent neoplasm after breast cancer in women and the third most frequent neoplasm after prostate and lung cancer in men. Survival at five years, if all stages are taken into account, …

According to research that has analysed the 100 most cited articles in the medical literature The territorial clinical director of chronic respiratory diseases at the Arnau de Vilanova University Hospital of Lleida (HUAV), professor at the Faculty of Medicine of the University of Lleida (UdL) …